Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


caLIMS v2

Product Description

Moxie Informatics builds custom LIMS software for the biotech industry designed to fit any size laboratory at an affordable price. From their work developing LIMS for the National Cancer Institute, Moxie is capable of providing generic solutions from many different laboratory settings.

Moxie Informatics is a health informatics company comprised of experts who are skilled and experienced in the business of Life Science research and Health Care. Their team is intimately familiar with the business of the National Cancer Institute and many of its offices and programs. Moxie’s team resources currently interface with NCI Directors, Program Managers and other government or contractor experts who are working within the CBIIT/caBIG enterprise. Their specific focus is in the areas of program management and providing innovative-value added information technology services to the scientific research community.

Developed by Moxie Informatics, the National Cancer Institute's caLIMS v2 project was launched to create a LIMS that is interoperable within established caBIG standards and guidelines and will track a complete laboratory workflow that uses materials from a specimen management service (e.g. caTissue) to generate experimental results for one of the caBIG data management services (e.g. caArray). The caLIMSv2.c3i0 milestone release is an early release version of the planned caLIMS v2.0 beta release. This caLIMSv2.c3i0 contains much of the functionality related to the administration, customer service, inventory, and reports modules, including: set up of laboratories and users, locations and storage, equipment and software; customer requests, services, and accounts; containers, specimens, reagents, and supplies; and queries, searches, and reports. The goal of this release is to allow the interested community full access to the project results so far for their evaluation, feedback, and possible local customization. Information on the release can be found on the National Cancer Institute's caLIMS v2 Project Wiki at http://www.cancer.gov.

Product caLIMS v2
Company Moxie Informatics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Moxie Informatics
155 Gibbs St., Suite 506 Rockville, MD 20855 USA

Tel: +1 866-205-3962

Email: info@moxieinforamtics.com



Scientific News
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!